<Warning Snarky mode on> I saw the following tweet on Twitter today and it got me to thinking and then writing:
DiabetesMine First-ever branded Tweet: Charlie Kimball on Levemir - good info, or just sleazy? http://tinyurl.com/m75wpf
First, I have to thank Charlie for getting me interested in Indy racing this year. Because of his interview with SUM, his tweets and his blogs, I've watched two Indy style races, Indianapolis and Texas Motorspeedway and I've got Iowa on the DVR. I'm also following some of my favorite Indy drivers.
Second, I've always wondering about the bloggers who make money -- especially those that make money on their chronic disease. I really like what David Mendosa writes and Amy makes me think.
I'll have to admit, blogging and writing is a hobby for me, and is a secondary means to an end, polishing up my technical writing. One of my next major projects, if my district ever gives me time, is to write a CS textbook. In the meantime, I do a lot of curriculum writing because what I do for my classroom.
I'd love to make a few cents on the lapband experience, but if I don't, well, I don't. And if I can help someone behind me on this mission cool.
That being said, if Charlie and Levemir think that tweeting will get both of them some attention, who is Amy to say it is sleezy? It's no more sleezy than her tweets which almost always promoting her blog or RTing someone else. Frankly I use Twitter to communicate and promoting the blog is secondary -- in fact, lately blogging is a way to write more than 140 characters, and communicating to my PON (personal online network) though PON can also be a cool herding dog (shout-out to Moseley, a PON)..
Hopefully I'm done being snarky today, but then who knows, I might still be in a snarky mood.
By the way, I love Novalog -- Humalog makes me itch, and I'm keeping Apridia around just in case Novalog starts making me itch too. And I keep wondering if Symlin has the same preservative as Humalog as it makes me itch too, but it doesn't last long. Pretty sure it does.
<Warning Snarky mode on> I saw the following tweet on Twitter today and it got me to thinking and then writing:
DiabetesMine First-ever branded Tweet: Charlie Kimball on Levemir - good info, or just sleazy? http://tinyurl.com/m75wpf
First, I have to thank Charlie for getting me interested in Indy racing this year. Because of his interview with SUM, his tweets and his blogs, I've watched two Indy style races, Indianapolis and Texas Motorspeedway and I've got Iowa on the DVR. I'm also following some of my favorite Indy drivers.
Second, I've always wondering about the bloggers who make money -- especially those that make money on their chronic disease. I really like what David Mendosa writes and Amy makes me think.
I'll have to admit, blogging and writing is a hobby for me, and is a secondary means to an end, polishing up my technical writing. One of my next major projects, if my district ever gives me time, is to write a CS textbook. In the meantime, I do a lot of curriculum writing because what I do for my classroom.
I'd love to make a few cents on the lapband experience, but if I don't, well, I don't. And if I can help someone behind me on this mission cool.
That being said, if Charlie and Levemir think that tweeting will get both of them some attention, who is Amy to say it is sleezy? It's no more sleezy than her tweets which almost always promoting her blog or RTing someone else. Frankly I use Twitter to communicate and promoting the blog is secondary -- in fact, lately blogging is a way to write more than 140 characters, and communicating to my PON (personal online network) though PON can also be a cool herding dog (shout-out to Moseley, a PON)..
Hopefully I'm done being snarky today, but then who knows, I might still be in a snarky mood.
By the way, I love Novalog -- Humalog makes me itch, and I'm keeping Apridia around just in case Novalog starts making me itch too. And I keep wondering if Symlin has the same preservative as Humalog as it makes me itch too, but it doesn't last long. Pretty sure it does.